_1568963013 1568963013 Editor editor.jddt@gmail.com UJPR Universal Journal of Pharmaceutical Research Univ J Pharm Res 2456-8058 04 11 2018 Ejiogu Deborah Chioma Etodolac is an indole acetic acid derivative with half-life of 4 to 7 hrs. It is used for the treatment of Rheumatoid arthritis. Whenever used orally, it has many systemic side effects, so it is not preferred orally. In present study four niosomes formulations of Etodolac were successfully developed by modified ether injection technique using different nonionic surfactant i.e. Span 20, Span 40, Tween 20, Tween 40 and cholesterol. Formulations were evaluated for different parameters like particle size, entrapment efficiency, in-vitro release, stability studies. Google Scholar 09 01 2016 10.22270/ujpr.v1i1.R1 http://ujpr.org/index.php/journal/article/view/11 http://ujpr.org/index.php/journal/article/download/11/7 http://ujpr.org/index.php/journal/article/download/11/190 http://ujpr.org/index.php/journal/article/download/11/7 http://ujpr.org/index.php/journal/article/download/11/190